Document is current
Any future updates will be listed below
-
Authors
Banda, Nirmal K.
Moreland, Larry W.
Deane, Kevin D.
Simberg, Dmitri
Scheinman, Robert I.
Frank, Rachel M.
Seifert, Jennifer A.
,
Anolik, Jennifer
Tabechian, Darren
Thiele, Ralf
Hossler, Jennifer
Boyce, Brendan
Meednu, Nida
Rangel-Moreno, Javier
Ritchlin, Christopher
Bykerk, Vivian
Donlin, Laura
Goodman, Susan
DiCarlo, Ed
Orange, Dana
Carrino, John
Yoshimi, Nwawka Endo
Satija, Rahul
Ivashkiv, Lionel
Pernis, Alessandra
Darnell, Robert
Figgie, Mark
McGeachy, Michael McNamara. Mandy J.
Kolls, Jay
Wise, Aaron
Horowitz, Andrew Cordle, Peter Gregersen Dian
Filer, Andrew D.
Adams, Jason Turner Holly
Hands, Stephen Kelly Rebecca
Wei, Kevin
Rao, Deepak
Mizoguchi, Fumitaka
Holers, V. Michael
Deane, Kevin D.
Seifert, Jennifer A.
Banda, Nirmal K.
Moreland, Larry W.
Merkle, Alexander
Strickland, Colin
Firestein, Gary S.
Boyle, David
Weisman, Michael H.
Ben-Artzi, Ami
Forbess, Lindsy
Gravallese, Ellen
Salomon-Escoto, Karen
Perlman, Harris
Bacalao, Arthur Mandelin Emily
Parks, Deborah
Atkinson, John
Bathon, Joan
Matteson, Eric
Lau, Rachel
Pitzalis, Costantino
Lewis, Myles J.
Holers, V. Michael
-
Funding
Funding for this research was provided by:
NIH (AR51749)
National Institute of Health United states (AR51749, AR51749)
- License Information
-
More Information
Article History
Received: 11 February 2025
Accepted: 21 May 2025
First Online: 4 June 2025
Declarations
:
: The authors declare no competing interests. NKB: royalties, and patents for the treatment of inflammatory diseases using anti-C5aR1ab-C5siRNA conjugate. LWM: none; KDD: none; DS, none; RIS: none; RMF: none; JS, none; RL: none; CP: none; MJL: none; VMH: royalties, consulting income, stock, and stock options in complement therapeutics companies.
: Written ethical informed consent was obtained from all eRA patients according to the preapproved Colorado Multiple Institutional Review Board protocol (COMIRB # 20-1908 and 15-1389). All methods were carried out in accordance with relevant guidelines and regulations. All experimental protocols related to these studies were approved by the Institutional Review Board committee.
